The effectiveness of a magnetic nanoparticle-based delivery system for BCNU in the treatment of gliomas.
Hua
Mu-Yi
MY
Molecular Medicine Research Center, Department of Chemical and Materials Engineering, Chang Gung University, Tao-Yuan, Taiwan, ROC. huamy@mail.cgu.edu.tw
Liu
Hao-Li
HL
Yang
Hung-Wei
HW
Chen
Pin-Yuan
PY
Tsai
Rung-Ywan
RY
Huang
Chiung-Yin
CY
Tseng
I-Chou
IC
Lyu
Lee-Ang
LA
Ma
Chih-Chun
CC
Tang
Hsiang-Jun
HJ
Yen
Tzu-Chen
TC
Wei
Kuo-Chen
KC
D000818:Animals; D018906:Antineoplastic Agents, Alkylating / Q000008:administration & dosage / Q000737:chemistry / Q000627:therapeutic use*; D002330:Carmustine / Q000008:administration & dosage / Q000737:chemistry / Q000627:therapeutic use*; D002460:Cell Line; D045744:Cell Line, Tumor; D016503:Drug Delivery Systems / Q000379:methods*; D005910:Glioma / Q000188:drug therapy* / Q000473:pathology / Q000648:ultrastructure; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D046529:Microscopy, Electron, Transmission; D053758:Nanoparticles / Q000737:chemistry*; D051381:Rats; D017207:Rats, Sprague-Dawley
D018906:Antineoplastic Agents, Alkylating; D002330:Carmustine